Scholars Central

Conference abstractPublished 3 Oct 2016

Obesity and breast cancer: Can an aspirin a day really improve survival?

Authors: Linda A. deGraffenried

The University of Texas at Austin, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Multiple studies have demonstrated that obesity is associated with a worse outcome for most breast cancer subtypes and that obese breast cancer patients do not respond as well as normal weight patients to hormone therapy as well as chemotherapy. While a number of reasons have been proposed to explain this link, including diagnosis bias and complications caused by co-morbidities such as Type II diabetes, recent studies have provided evidence that elevated local cyclooxygenase-2 (COX-2) expression and the resulting increase in prostaglandin E2 (PGE2) production may play an important role. COX-2 upregulation in breast tumors is associated with a poor prognosis, a connection generally attributed to PGE2's direct effects on apoptosis and invasion as well as its stimulation of pre-adipocyte aromatase expression and subsequent estrogen production. Research in this area has provided a strong foundation for the hypothesis that COX-2 signaling is involved in the obesity-breast cancer link. Our recent pre-clinical and clinical data suggest that this inflammation-related signaling modulates several pathways critical to cancer progression in the obese breast cancer patient – but importantly – suppression of this signaling through fairly non-toxic approaches may provide significant clinical benefit and improve response to standard therapies – which will be critical as obesity reaches epidemic levels world-wide

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectObesity & Weight Management
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Linda A. deGraffenried”